[1]罗杨敏,孙维旭,王银菊,等.六君子汤联合西药治疗慢性肺炎疗效及对患者肺功能的影响*[J].陕西中医,2018,(11):1540-1543.
　Luo Yangmin,Sun Weixu,Wang Yinju,et al.Effect of Liujunzi decoction combined with western medicine on chronic pulmonary infection and its influence on lung function[J].,2018,(11):1540-1543.
点击复制

六君子汤联合西药治疗慢性肺炎疗效及对患者肺功能的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2018年11期
页码:
1540-1543
栏目:
临床研究
出版日期:
2018-12-31

文章信息/Info

Title:
Effect of Liujunzi decoction combined with western medicine on chronic pulmonary infection and its influence on lung function
文章编号:
10.3969/j.issn.1000-7369.2018.11.015
作者:
罗杨敏; 孙维旭; 王银菊; 杨秀青; 郭利娟
河南省濮阳市中医医院肺病科(濮阳 457000)
Author(s):
Luo Yangmin; Sun Weixu;  Wang Yinju;  et al.
Department of Pulmonary Disease, Puyang Hospital of Traditional Chinese Medicine(Puyang 45700)
关键词:
肺炎 /中西医结合疗法抗感染药六君子汤/治疗应用
Keywords:
Pneumonia/integratedChinese traditional and western medicine therapyAnti-infective agentsLiu Jun Zi Tang/therapeutic uses
分类号:
R563.1
文献标志码:
A
摘要:
目的： 探讨六君子汤联合西药治疗慢性肺炎的疗效及对患者肺功能的影响。方法：选择慢性肺炎患者82例为研究对象。采用随机数字表分组法将其分为对照组和观察组，各41例。所有患者均给予吸氧、祛痰、止咳、纠正支气管扩张、维持水电解质以及酸碱度平衡等相关对症治疗。对照组根据痰培养结果选择合适的抗生素进行抗感染治疗，观察组在对照组基础上给予六君子汤治疗，比较两组治疗前、治疗3个疗程后肺功能、肺炎改善情况及其临床疗效。结果：治疗后1、2、3个月，两组患者中医症状积分均明显下降，且观察组比对照组下降更明显（P<0.05）。两组治疗前FVC、FEV1、FEV1%比较差异均无统计学意义（P>0.05）；两组治疗后FVC、FEV1、FEV1%水平均显著升高（P<0.05）；观察组治疗后FVC、FEV1、FEV1%水平均高于对照组（P<0.05）；两组治疗后WBC、CRP、肺炎指数和APACHEII评分均明显下降，且观察组比对照组更明显（P<0.05）。两组治疗前CD3+T、CD4+T、CD8+ T及CD4+T/CD8+ T比较差异无统计学意义（P>0.05）；两组治疗后CD3+T水平均无明显变化（P>0.05），CD4+T及CD4+T/CD8+ T水平均显著升高（P<0.05），CD8+ T水平显著降低（P<0.05）；观察组治疗后CD4+T及CD4+T/CD8+ T水平明显高于对照组（P<0.05），CD8+ T水平明显低于对照组（P<0.05）。两组治疗后生活质量评分显著升高，与治疗前比较差异有统计学意义（P<0.05）。随访12个月，两组复发率比较差异无统计学意义（P>0.05）。结论： 六君子汤联合西医治疗可显著改善慢性肺炎患者肺功能及肺炎情况，临床疗效确切。
Abstract:
Objective:To investigate the effect of Liujunzi decoction combined with western medicine on chronic pulmonary infection and its influence on lung function. Methods: 82 patients with chronic pulmonary infection admitted as the research subjects. They were divided into control group and observation group by random number table grouping method, 41 cases in each group. All patients were given oxygen inhalation, expectorant, cough, correction of bronchiectasis, maintenance of water and electrolyte and acid-base balance and other symptomatic treatment. The control group selected appropriate antibiotics for anti infection treatment according to the results of sputum culture. The observation group was treated with Liujunzi decoction on the basis of the control group. The improvement of lung function and pulmonary infection and its clinical effect were compared between the two groups before and after 3 courses of treatment. Results :After 1, 2, and 3 months of treatment, the scores of TCM symptoms in the two groups decreased significantly, and the observation group decreased more significantly than the control group (P< 0.05). There was no significant difference in FVC, FEV1 and FEV1% before treatment in the two groups (P>0.05), and the levels of FVC, FEV1 and FEV1% in the two groups were significantly higher (P<0.05) after treatment, and the levels of FVC, FEV1 and FEV1% in the observation group were higher than those of the control group (P<0.05), and the two groups were significantly decreased after treatment. And the observation group was more obvious than the control group (P<0.05). There was no significant difference between the two groups before the treatment of CD3+T, CD4+T, CD8+ T and CD4+T/CD8+ T (P>0.05), and there was no significant change in the level of CD3+T in the two groups (P>0.05). The average level of CD4+T and CD4+T/CD8+ T water was significantly higher. It was significantly higher than that in the control group (P<0.05), and the level of CD8+ T was significantly lower than that in the control group (P<0.05). The quality of life scores of the two groups increased significantly〖LM〗 after treatment, and the difference was statistically significant (P<0.05). Follow up for 12 months, there was no significant difference in recurrence rate between the two groups (P>0.05). Conclusion : Liujunzi decoction combined with western medicine can significantly improve the pulmonary function and pulmonary infection in patients with chronic pulmonary infection. It is effective in clinical treatment and can be used in the clinical treatment of chronic pulmonary infection.

参考文献/References:

[1]张佩玲.血栓前状态标志物监测在治疗复发性流产中的临床价值[J].辽宁医学杂志,2017,31(5):3-5.
[2]伍萍芝,蒙瞻瞻,严提珍.不明复发性流产封闭抗体及淋巴细胞免疫表型检测对淋巴细胞主动免疫治疗效果的评估价值[J].贵州医药,2017,41(6):598-600.
[3]Talebiar,Fesahatf,Mangolie,et al. Relationship between sperm protamine deficiency and apoptosis in couples with unexplained repeated spontaneous abortions[J]. Int J Reprod Biomed (yazd) ,2016,14(3):199-204.
[4]王燕,林娜,陈雪美,等.反复自然流产患者淋巴细胞主动免疫的治疗效果及其与HLA相关性研究[J].海南医学,2018,29(1):59-61.
[5]黎丽芬.淋巴细胞主动免疫治疗封闭抗体缺乏所致反复流产的疗效观察[J].中国实用医药,2017,12(10):78-80.
[6]Liu Z,Xu H,Kang X,et al. Allogeniclymphocyte immunotherapy for unexplained recurrent spontaneous abortion:ameta-analysis[J].Am Jreprod Immunol,2016,76(6):443-453.
[7]中华医学会妇产科学分会产科学组.复发性流产诊治的专家共识[J].中华妇产科杂志,2016,51(1):3-9.
[8]焦艳,王蒙,李欣.150例反复性自然流产患者封闭抗体的检测与治疗分析[J].国际检验医学杂志,2018,39(6):744-746.
[9]石瑛,王云凤,任静静,等.淋巴细胞主动免疫联合丙种球蛋白治疗复发性流产的Meta分析[J].中国妇幼保健,2018,33(6):1429-1434.
[10]叶艳琴,胡玥玥,张昌军.淋巴细胞主动免疫治疗结合心理干预对复发性流产患者封闭抗体水平及妊娠结局的影响[J].中国临床研究,2017,30(9):1240-1243.
[11]史晓艳,陈铭,石玉玲.淋巴细胞主动免疫治疗对封闭抗体阴性复发性流产后患者外周血Th1/Th2/Th17细胞因子表达水平变化[J].陕西医学杂志,2017,46(10):1407-1409.
[12]Motak-pochrzsth,Malinowskia.The efficacy of paternal lymphocytes immunizations in patients with recurrent miscarriages and the presence of autoantibodies[J].J Reprod Iimmunol,2016,(115): 68-68.
[13]Sacksg. Enough! stop the arguments and get on with the science of natural killer cell testing[J]. Hum Reprod,2015,30(7):1526-1531.
[14]叶平,董盼攀,王欢欢,等.中药联合淋巴细胞主动免疫治疗母-胎免疫识别低下型复发性流产的Meta分析[J].中华中医药学刊,2016,34(3):648-650.
[15]刘芦屏,孙丽,郑晶,等.补肾活血健脾法联合低频治疗复发性流产的临床观察[J].陕西中医,2016,37(11):1501-1503.
[16]王文娟,杨雁鸿,卢宗林.补肾祛瘀法分期治疗子宫内膜异位症性不孕症疗效观察[J].中国民族民间医药,2018,27(8):83-84.

备注/Memo

备注/Memo:
*河南省医学科技攻关计划项目（201402040）
更新日期/Last Update: 2018-11-30